Calamp share price today

(CAMP)

Calamp share price is $6.9 & ₹587.87 as on 25 Dec 2024, 2.30 'hrs' IST

$6.9

▲

-0.68

(-8.97%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Calamp share price in Dollar and Rupees. Guide to invest in Calamp from India. Also see the sentimental analysis on Indian investors investing in Calamp. Get details on the Indian mutual funds that are investing in Calamp. Get Analyst recommendations and forecasts along with all the Calamp's financials.

Calamp share price movements

Today's Low: $6.81
Today's High: $7.47
$6.90
1.3%
Downside
Day's Volatility :8.84%
Upside
7.63%
52 Weeks Low: $0.65
52 Weeks High: $12.30
$6.90
90.58%
Downside
52 Weeks Volatility :94.72%
Upside
43.9%

Calamp Returns

Period	Calamp Corp.	Sector (Technology)	Index (Russel 2000)
3 Months	-35.63%	5.9%	0.0%
6 Months	-35.63%	6.3%	0.0%
1 Year	23.97%	24.7%	0.0%
3 Years	-96.04%	39.1%	-21.1%

Calamp Key Statistics

in dollars & INR

Previous Close	$7.58
Open	$7.1
Today's High	$7.47
Today's Low	$6.81
Today's Volume	$66.8K
52 Week High	$12.3
52 Week Low	$0.65
Revenue TTM	$0.0
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

How to invest in Calamp from India?

It is very easy for Indian residents to invest directly in Calamp from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Calamp stock in both Indian Rupees (INR) and US Dollars (USD). Search for Calamp or CAMP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Calamp or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Calamp shares which would translate to 0.123 fractional shares of Calamp as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Calamp, in just a few clicks!

Returns in Calamp for Indian investors in Rupees

Investment Value

₹1,00,000

Calamp investment value today

Current value as on today

₹1,26,117

Returns

₹26,117

(+26.12%)

Returns from Calamp Stock

₹23,878 (+23.88%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Calamp

-34%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Calamp on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -34% less investors are searching Calamp in the last 30 days versus the previous period.

Global Institutional Holdings in Calamp

West Paces Advisors Inc
0.01%

Analyst Recommendation on Calamp

Sell

11%Buy

44%Hold

44%Sell

Based on 9 Wall street analysts offering stock ratings for Calamp(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Calamp

What analysts predicted

Downside of 74.35%

Current:

$6.90

Target:

$1.77

Insights on Calamp

Price Movement
In the last 3 months, CAMP stock has moved up by 945.2%
Decreasing Revenue
Revenue is down for the last 9 quarters, 78.88M → 53.62M (in $), with an average decrease of 4.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 5 quarters, -4.03M → -85.00M (in $), with an average decrease of 479.2% per quarter
CAMP vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 2.1%
CAMP vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 121.3%

Calamp Financials in INR & Dollars

	FY21	Y/Y Change
Revenue	$295.8M	↓ 4.13%
Net Income	$-31.1M	↑ 47.22%
Net Profit Margin	-10.53%	↓ 3.67%

	FY22	Y/Y Change
Revenue	$294.9M	↓ 0.3%
Net Income	$-32.5M	↑ 4.31%
Net Profit Margin	-11.02%	↓ 0.49%

	FY22	Y/Y Change
Revenue	$294.9M	↓ 0.3%
Net Income	$-32.5M	↑ 4.31%
Net Profit Margin	-11.02%	↓ 0.49%

	FY23	Y/Y Change
Revenue	$186.2M	↓ 36.86%
Net Income	$-93.3M	↑ 187.05%
Net Profit Margin	-50.08%	↓ 39.06%

	FY23	Y/Y Change
Revenue	$186.2M	↓ 36.86%
Net Income	$-93.3M	↑ 187.05%
Net Profit Margin	-50.08%	↓ 39.06%

	FY24	Y/Y Change
Revenue	$186.2M	↑ 0.0%
Net Income	$-93.3M	↑ 0.0%
Net Profit Margin	-50.08%	↑ 0.0%

	Q2 FY23	Q/Q Change
Revenue	$70.9M	↑ 0.0%
Net Income	$-4.0M	↑ 0.0%
Net Profit Margin	-5.69%	↑ 0.0%

	Q2 FY23	Q/Q Change
Revenue	$70.9M	↑ 0.0%
Net Income	$-4.0M	↑ 0.0%
Net Profit Margin	-5.69%	↑ 0.0%

	Q3 FY23	Q/Q Change
Revenue	$61.7M	↑ 0.0%
Net Income	$-4.2M	↑ 0.0%
Net Profit Margin	-6.85%	↑ 0.0%

	Q3 FY23	Q/Q Change
Revenue	$61.7M	↑ 0.0%
Net Income	$-4.2M	↑ 0.0%
Net Profit Margin	-6.85%	↑ 0.0%

	Q4 FY23	Q/Q Change
Revenue	$53.6M	↑ 0.0%
Net Income	$-85.0M	↑ 0.0%
Net Profit Margin	-158.52%	↑ 0.0%

	Q4 FY23	Q/Q Change
Revenue	$53.6M	↑ 0.0%
Net Income	$-85.0M	↑ 0.0%
Net Profit Margin	-158.52%	↑ 0.0%

	FY21	Y/Y Change
Profit	$121.9M	-

	FY22	Y/Y Change
Profit	$109.0M	-

	FY23	Y/Y Change
Profit	$67.0M	-

	Q2 FY23	Q/Q Change
Profit	$27.1M	-

	Q3 FY23	Q/Q Change
Profit	$22.3M	-

	Q4 FY23	Q/Q Change
Profit	$17.6M	-

	FY21	Y/Y Change
Operating Cash Flow	$28.6M	↑ 0.0%
Investing Cash Flow	$-13.7M	-
Financing Cash Flow	$-27.3M	↑ 0.0%

	FY22	Y/Y Change
Operating Cash Flow	$-4.2M	↑ 0.0%
Investing Cash Flow	$-7.6M	-
Financing Cash Flow	$-2.6M	↑ 0.0%

	FY23	Y/Y Change
Operating Cash Flow	$-22.9M	↑ 0.0%
Investing Cash Flow	$-11.1M	-
Financing Cash Flow	$-909.0K	↑ 0.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-3.0M	↑ 173.14%
Investing Cash Flow	$-2.0M	-
Financing Cash Flow	$-257.0K	↓ 197.35%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$7.1M	↓ 339.7%
Investing Cash Flow	$-1.9M	-
Financing Cash Flow	$-114.0K	↓ 55.64%

Calamp Technicals Summary

Sell

Neutral

Buy

Calamp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Calamp Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Calamp Corp.	39.68%	-35.63%	23.97%	-96.04%	-96.78%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Calamp Corp.	NA	NA	NA	0.0	0.0	0.0	NA	NA
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Calamp Corp.	Sell	$660.3K	-96.78%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Calamp

calamp (nasdaq: camp) is leading the internet of things revolution with its extensive portfolio of intelligent communications devices, robust and capable cloud platform, and targeted software applications. calamp enables customers to optimize operations by collecting, monitoring and efficiently reporting business-critical data and desired intelligence from high-value remote assets. with a heritage in the m2m market, calamp has more than five million devices connected to its iot cloud. partners across transportation, oil and gas, and public safety markets leverage calamp to effectively gather mission- and business-critical data to make intelligent, actionable decisions. for more information, please visit www.calamp.com.

Organization	Calamp
Employees	58
CEO	Mr. Joshua Mandel-Brehm
Industry	Telecommunications Equipment

Management People of Calamp

Name	Title
Mr. Joshua Mandel-Brehm	CEO, President & Director
Dr. Richard A. Young Ph.D.	Founder & Independent Director
Ms. Kelly Gold	Chief Financial Officer
Dr. David Bumcrot Ph.D.	Chief Scientific Officer & Senior Vice President of Research
Dr. Leonard I. Zon M.D.	Founder
Mr. Caleb Moore	Chief Business Operations Officer & SVP of Portfolio Strategy & Business Operations
Ms. Michelle Gates	Senior VP & Chief People Officer
Dr. Satya Kuchimanchi Ph.D.	Senior Vice President of Technical Operations
Dr. Daniel Tardiff Ph.D.	VP & Head of Discovery
Dr. Yuri Maricich M.B.A., M.D.	Chief Medical Officer

Important FAQs about investing in Calamp from India :

What is Calamp share price today?

Calamp share price today stands at $6.90, Open: $7.10 ; Previous Close: $7.58 ; High: $7.47 ; Low: $6.81 ; 52 Week High: $12.30 ; 52 Week Low: $0.65. The stock opens at $7.10, after a previous close of $7.58. The stock reached a daily high of $7.47 and a low of $6.81, with a 52-week high of $12.30 and a 52-week low of $0.65.

Can Indians buy Calamp shares?

Yes, Indians can invest in the Calamp (CAMP) from India.

With INDmoney, you can buy Calamp at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Calamp at zero transaction cost.

How can I buy Calamp shares from India?

It is very easy to buy Calamp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Calamp be purchased?

Yes, you can buy fractional shares of Calamp with INDmoney app.

What are the documents required to start investing in Calamp stocks?

To start investing in Calamp, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.